Compounds > fluorouracil

fluorouracil and mofarotene

fluorouracil has been researched along with mofarotene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chastre, E; Empereur, S; Fagot, D; Forgue-Lafitte, E; Gespach, C; Louvet, C; Mester, J; Zimber, A1
Eliason, JF; Hartmann, D; Horii, I; Inoue, T; Kubota, A1
Djelloul, S; Forgue-Lafitte, ME; Gespach, C; Louvet, C; Mester, J; Zimber, A1

Other Studies

3 other study(ies) available for fluorouracil and mofarotene

ArticleYear
The arotinoid Ro 40-8757 has antiproliferative effects in drug-resistant human colon and breast cancer cell lines in vitro.
    Cancer letters, 1994, Sep-30, Volume: 85, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Division; Colonic Neoplasms; Doxorubicin; Drug Resistance, Multiple; Fluorouracil; Humans; Morpholines; Retinoids; Tumor Cells, Cultured

1994
The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of 5-fluorouracil.
    International journal of cancer, 1994, Apr-15, Volume: 57, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Female; Fluorouracil; Hematopoietic Stem Cells; Mammary Neoplasms, Experimental; Morpholines; Rats; Rats, Sprague-Dawley; Retinoids

1994
Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha.
    British journal of cancer, 1996, Volume: 74, Issue:3

    Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Drug Synergism; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Morpholines; Pancreatic Neoplasms; Protein Kinase C; Retinoids; Tumor Cells, Cultured

1996